{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:25:20Z","timestamp":1787617520570,"version":"build-2736575974"},"reference-count":30,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["HSRIC-2016-10009"],"award-info":[{"award-number":["HSRIC-2016-10009"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2026,3,14]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide intelligence and foresight about persistent evidence gaps in medicines for children and young people experiencing gender incongruence or dysphoria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A horizon scan, with foresight analysis, of clinical trial registries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Global.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Children and young people (aged 0\u201317 years) experiencing gender incongruence or dysphoria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Any medicine under evaluation in an ongoing study registered on a clinical trial registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Any.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 15 ongoing studies across 23 registries with a total actual or planned sample size of 1073. Twelve studies were based in the USA. The medicine classes under evaluation were limited to gonadotrophin-releasing hormone analogues\/agonists, cross-sex\/gender-affirming hormones, anti-androgen therapy and progesterone therapy. Target populations were primarily older adolescents. Outcomes most commonly assessed were body structure and functions related to puberty\/reproduction (n=6 studies) and body structures related to brain, blood vessels or heart (n=5), followed by bone structures (n=4), fat mass\/body mass index (n=4), metabolic functions (n=4) and gender identity, gender\/body image or gender dysphoria (n=3). The contributions of the studies on effectiveness and safety will be restricted because many do not use a control group (8\/15 studies), random allocation (11\/15) or blinding (12\/15).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ongoing studies are unlikely to provide substantial new evidence to address evidence gaps in effectiveness or safety of medicines for children and young people experiencing gender incongruence or dysphoria. It will depend on new studies, including NHS England\u2019s trial of puberty-suppressing treatments, with adequate power, rigorous designs and inclusion of all relevant outcomes, to provide such evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2025-329435","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:13Z","timestamp":1787616013000},"page":"archdischild-2025-329435","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Medicines for children and young people who seek support around gender: a horizon scanning study of the emerging medicines pipeline"],"prefix":"10.1136","author":[{"given":"Gill","family":"Norman","sequence":"first","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-5282","authenticated-orcid":false,"given":"Ross","family":"Fairbairn","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dobson","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizoba","family":"Oparah","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayomikun","family":"Ogunyemi","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-9913","authenticated-orcid":false,"given":"Niina","family":"Kolehmainen","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2026082417000620000_archdischild-2025-329435v1.1","unstructured":"Cass H . Independent review of gender identity services for children and young people: final report. 2024. Available: https:\/\/cass.independent-review.uk\/home\/publications\/final-report\/"},{"key":"2026082417000620000_archdischild-2025-329435v1.2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-326112"},{"key":"2026082417000620000_archdischild-2025-329435v1.3","article-title":"Psychosocial support interventions for children and adolescents experiencing gender dysphoria or incongruence: a systematic review","volume":"109","author":"Heathcote","year":"2024","journal-title":"Arch Dis Child"},{"key":"2026082417000620000_archdischild-2025-329435v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-326681"},{"key":"2026082417000620000_archdischild-2025-329435v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-326760"},{"key":"2026082417000620000_archdischild-2025-329435v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-326669"},{"key":"2026082417000620000_archdischild-2025-329435v1.7","article-title":"Masculinising and feminising hormone interventions for adolescents experiencing gender dysphoria or incongruence: a systematic review","volume":"109","author":"Taylor","year":"2024","journal-title":"Arch Dis Child"},{"key":"2026082417000620000_archdischild-2025-329435v1.8","unstructured":"NHS England . Updated information for primary care - government restrictions on use of puberty suppressing hormones (puberty blockers). 2024. Available: https:\/\/www.rpharms.com\/Portals\/0\/RPS%20document%20library\/Open%20access\/Support%20alert\/PRN01743_ii%20-%20UPDATED%20-%20Government%20restrictions%20on%20use%20of%20puberty%20suppressing%20hormones%20-%20information%20for%20primary%20care_December%202024%20(002).pdf?ver=cjOHEGmWXa6gnz6A0gKW0Q%3d%3d"},{"key":"2026082417000620000_archdischild-2025-329435v1.9","unstructured":"King\u2019s College London . Pathways: puberty suppression and transitional healthcare with adaptive youth services. 2026. Available: https:\/\/www.kcl.ac.uk\/research\/pathways"},{"key":"2026082417000620000_archdischild-2025-329435v1.10","doi-asserted-by":"crossref","DOI":"10.1002\/ffo2.210","article-title":"Horizon Scanning Methods for Identification of New and Repurposed Medicines for Stakeholders in the United Kingdom","volume":"7","author":"Khan","year":"2025","journal-title":"Futur Foresight Sci"},{"key":"2026082417000620000_archdischild-2025-329435v1.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026764","article-title":"Scanning the horizon: a systematic literature review of methodologies","volume":"9","author":"Hines","year":"2019","journal-title":"BMJ Open"},{"key":"2026082417000620000_archdischild-2025-329435v1.12","unstructured":"McKinsey & Company . Enduring ideas: the three horizons of growth. McKinsey quarterly. 2009. Available: https:\/\/www.mckinsey.com\/capabilities\/strategy-and-corporate-finance\/our-insights\/enduring-ideas-the-three-horizons-of-growth"},{"key":"2026082417000620000_archdischild-2025-329435v1.13","unstructured":"NIHR Innovation Observatory. ScanMedicine. n.d. Available: https:\/\/scanmedicine.com\/"},{"key":"2026082417000620000_archdischild-2025-329435v1.14","doi-asserted-by":"crossref","first-page":"107042","DOI":"10.1016\/j.cct.2022.107042","article-title":"ScanMedicine: An online search system for medical innovation","volume":"125","author":"Sadek","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2026082417000620000_archdischild-2025-329435v1.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13034-023-00654-3","article-title":"A systematic review on gender dysphoria in adolescents and young adults: focus on suicidal and self-harming ideation and behaviours","volume":"17","author":"Marconi","year":"2023","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2026082417000620000_archdischild-2025-329435v1.16","doi-asserted-by":"publisher","DOI":"10.1089\/trgh.2020.0094"},{"key":"2026082417000620000_archdischild-2025-329435v1.17","unstructured":"International Classification of Functioning, Disability and Health (ICF). Geneva World Health Organization; 2018. Available: https:\/\/www.who.int\/standards\/classifications\/international-classification-of-functioning-disability-and-health"},{"key":"2026082417000620000_archdischild-2025-329435v1.18","unstructured":"NHS . Treatment - gender dysphoria. 2020. Available: https:\/\/www.nhs.uk\/conditions\/gender-dysphoria\/treatment\/"},{"key":"2026082417000620000_archdischild-2025-329435v1.19","doi-asserted-by":"crossref","DOI":"10.52965\/001c.38358","article-title":"Gender Dysphoria and Its Non-Surgical and Surgical Treatments","volume":"10","author":"Anderson","year":"2022","journal-title":"Health Psychol Res"},{"key":"2026082417000620000_archdischild-2025-329435v1.20","unstructured":"Deutsch MB . Overview of feminizing hormone therapy. UCSF transgender care. San Francisco University of California; 2016. Available: https:\/\/transcare.ucsf.edu\/guidelines\/feminizing-hormone-therapy"},{"key":"2026082417000620000_archdischild-2025-329435v1.21","unstructured":"Office for Health Improvement & Disparities . Official statistics: obesity profile: statistical commentary. 2024. Available: https:\/\/www.gov.uk\/government\/statistics\/obesity-profile-november-2024-update\/obesity-profile-statistical-commentary-november-2024"},{"key":"2026082417000620000_archdischild-2025-329435v1.22","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.ssmmh.2022.100176","article-title":"Socio-economic inequalities in adolescent mental health in the UK: Multiple socio-economic indicators and reporter effects","volume":"2","author":"Hazell","year":"2022","journal-title":"SSM - Mental Health"},{"key":"2026082417000620000_archdischild-2025-329435v1.23","unstructured":"Public Health England . Research and analysis: differences in child obesity by ethnic group. 2019. Available: https:\/\/www.gov.uk\/government\/publications\/differences-in-child-obesity-by-ethnic-group\/differences-in-child-obesity-by-ethnic-group"},{"key":"2026082417000620000_archdischild-2025-329435v1.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-20695-3","article-title":"Associations between ethnicity and mental health problems among children and adolescents in the United Kingdom: A systematic review and narrative synthesis","volume":"24","author":"Guan","year":"2024","journal-title":"BMC Public Health"},{"key":"2026082417000620000_archdischild-2025-329435v1.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026082417000620000_archdischild-2025-329435v1.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081904","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"2026082417000620000_archdischild-2025-329435v1.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081905","article-title":"Core GRADE 3: rating certainty of evidence\u2014assessing inconsistency","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"2026082417000620000_archdischild-2025-329435v1.28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/cpt.3576","article-title":"Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective","volume":"117","author":"Chen","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"2026082417000620000_archdischild-2025-329435v1.29","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-318676"},{"key":"2026082417000620000_archdischild-2025-329435v1.30","unstructured":"NIHR Bristol Evidence Synthesis Group . Supporting children and young people experiencing gender dysphoria or incongruence: a programme of evidence syntheses. 2026. Available: https:\/\/bristol-esg.org\/projects-2\/gen\/"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2025-329435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:18Z","timestamp":1787616018000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2025-329435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":30,"alternative-id":["10.1136\/archdischild-2025-329435"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2025-329435","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}